There are situations in the day to day practice of C/P Psychiatry when are confronted with life threatening situations that require the immediate identification and timely management. Dr Maldonado will discuss three such psychiatric emergencies: Central Anticholinergic Syndrome, Serotonin Syndrome, and Neuroleptic malignant Syndrome. For each of these conditions we will discuss typical and atypical presentations, diagnostic criteria and methodology, best treatment practices, and pitfalls to avoid.
While psychotic disorders are the most common causes of hallucinations, there are important to medical and neurological disorders that lead to hallucinations. Dr Zein will discuss Charles Bonnet and Oliver Sachs syndromes, complex “release” syndromes caused by damage to the visual and auditory circuits with resultant hallucinations that are often (but not always) due to changes in vision and hearing. Then, gustatory and olfactory hallucinations and their links to epileptic seizures as well as malignancy are explored. Finally, tactile hallucinations, especially related to Parkinson’s disease, phantom limb, and medication/substance use are discussed. For each hallucination type, pathophysiology, differential and treatment evidence will be presented.
Multiple sclerosis is, by far, the most common inflammatory demyelinating disease of the central nervous system affecting more than two million people worldwide. However, MS is not the only CNS inflammatory demyelinating disease, and there is abroad spectrum of disorders with varied clinical course, imaging features, and pathology. This cohort of diseases are associated with a broad array of neuropsychiatric problems that are commonly linked to poorer quality of life, increase in suicidal ideation, potential cognitive impairment and less adherance to disease-modifying therapy. Dr Schmajuk will discuss and review the clinical features of neuropsychiatric burden of inflammatory demyelinating disease and consider treatment interventions for this population.
CL psychiatrists are often asked to co-manage psychiatric symptoms that occur in patients with movement disorders such as Parkinson's Disease and Huntington's Disease. Dr. Ament will review both PD and HD, highlighting common psychiatric symptoms and the approach to treatment. Additionally, Dr. Ament will review and discuss the differential diagnosis of dyskinesias encountered in the general hospital setting, such as tremor and myoclonus.
Fatigue is a multidimensional, distressing experience for patients suffering from many conditions, including neurological, inflammatory, and autoimmune diseases. Patients with disorders, such as Fibromyalgia, CFS, IBS, suffer from fatigue as a prominent feature of their illness and can endure social consequences, comorbid psychiatric symptoms, sleep disturbances, and cognitive impairment. In this session, Dr. Lahijani will discuss the etiologies of fatigue in these disorders, including proinflammatory cytokines, oxidative stress, disruptions to the HPA-axis, and genetics, as well as describe the neuropsychiatric presentations of fatigue that CL psychiatrists encounter in clinical practice, and also present associated treatment options.